See the DrugPatentWatch profile for Metoprolol
What is metoprolol ER (metoprolol succinate) used for?
Metoprolol ER (metoprolol succinate) is an extended-release beta blocker used to treat conditions such as high blood pressure and some heart-related conditions. It works by slowing the heart rate and lowering strain on the heart.
How is metoprolol ER (succinate) different from metoprolol tartrate?
Metoprolol ER is a once-daily, extended-release formulation that releases the drug more slowly. Metoprolol tartrate is an immediate-release form that is typically dosed more than once per day. Both contain metoprolol, but the dosing schedules and release characteristics differ.
How should metoprolol ER (succinate) be taken?
Metoprolol ER is generally taken once daily with consistent timing. Patients should not crush or chew ER tablets unless the product instructions specifically allow it. If a dose is missed, the usual approach is to take it when remembered unless it’s close to the next scheduled dose—follow the prescribing instructions or pharmacist guidance.
What side effects are patients asking about?
Common beta-blocker side effects can include tiredness/fatigue, dizziness, slow heart rate (bradycardia), and low blood pressure (lightheadedness). Some patients also report shortness of breath or cold hands/feet. Seek urgent care for symptoms like fainting or severe breathing problems.
Can metoprolol ER be stopped suddenly?
Stopping beta blockers abruptly can worsen heart symptoms for some people. Clinicians usually taper the dose rather than stopping at once, especially in patients with heart disease. Patients should follow their prescriber’s instructions for any dose changes.
What drug interactions matter most?
Beta blockers can interact with other medicines that lower heart rate or blood pressure. Examples include certain calcium channel blockers and other rate-slowing drugs, plus some medications that affect how metoprolol is metabolized. Alcohol can also increase dizziness or low blood pressure in some patients.
Who makes metoprolol ER (succinate), and is it covered by patents?
Metoprolol ER (metoprolol succinate) is widely available and generally treated as an older, off-patent medicine in most markets. For up-to-date patent and exclusivity details for specific manufacturers/products, DrugPatentWatch.com provides searchable coverage.
Sources
1. https://www.drugpatentwatch.com/